These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Immunological identification of a high molecular weight protein as a candidate for the product of the Duchenne muscular dystrophy gene. Kao L; Krstenansky J; Mendell J; Rammohan KW; Gruenstein E Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4491-5. PubMed ID: 3288996 [TBL] [Abstract][Full Text] [Related]
63. Dystrophin assay in muscular dystrophies: an Indian experience. Jain S; Sarkar C; Dinda AK; Maheshwari MC Natl Med J India; 1993; 6(6):259-62. PubMed ID: 7950930 [TBL] [Abstract][Full Text] [Related]
68. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. Vilquin JT; Wagner E; Kinoshita I; Roy R; Tremblay JP J Cell Biol; 1995 Nov; 131(4):975-88. PubMed ID: 7490298 [TBL] [Abstract][Full Text] [Related]
69. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy]. Wang S; Shen D Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148 [TBL] [Abstract][Full Text] [Related]
72. Immunohistochemistry in the diagnosis of dystrophinopathies. Manole E Rom J Neurol Psychiatry; 1995; 33(1):51-5. PubMed ID: 7547371 [TBL] [Abstract][Full Text] [Related]
73. Abnormal localization of laminin subunits in muscular dystrophies. Hayashi YK; Engvall E; Arikawa-Hirasawa E; Goto K; Koga R; Nonaka I; Sugita H; Arahata K J Neurol Sci; 1993 Oct; 119(1):53-64. PubMed ID: 8246011 [TBL] [Abstract][Full Text] [Related]
74. Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders. Uchino M; Araki S; Miike T; Teramoto H; Nakamura T; Yasutake T Muscle Nerve; 1989 Dec; 12(12):1009-16. PubMed ID: 2695839 [TBL] [Abstract][Full Text] [Related]
75. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Partridge TA; Morgan JE; Coulton GR; Hoffman EP; Kunkel LM Nature; 1989 Jan; 337(6203):176-9. PubMed ID: 2643055 [TBL] [Abstract][Full Text] [Related]
76. Monoclonal antibodies targeted against the C-terminal domain of dystrophin or utrophin. Fabbrizio E; Léger J; Anoal M; Léger JJ; Mornet D FEBS Lett; 1993 May; 322(1):10-4. PubMed ID: 8482362 [TBL] [Abstract][Full Text] [Related]
77. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation]. Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277 [TBL] [Abstract][Full Text] [Related]
78. Genetic and biochemical determinations in the pre-transplant workup and in the post-transplant assessment period. Worton RG; Bulman DE; Zubrzycka-Gaarn EE; Ray PN Adv Exp Med Biol; 1990; 280():219-25; discussion 225-6. PubMed ID: 2248141 [No Abstract] [Full Text] [Related]
79. [Muscle cultures and immunocytochemical study of dystrophin in patients with Duchenne muscular dystrophy and control patients]. Watanabe Y; Yakata N; Wakai S; Oya K; Chiba S No To Hattatsu; 1992 Nov; 24(6):602-5. PubMed ID: 1419176 [No Abstract] [Full Text] [Related]
80. Dystrophin and nebulin in the muscular dystrophies. Patel K; Voit T; Dunn MJ; Strong PN; Dubowitz V J Neurol Sci; 1988 Nov; 87(2-3):315-26. PubMed ID: 3062133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]